Healthcare & Life Sciences
Aurinia Pharmaceuticals
Canada
About
Aurinia Pharmaceuticals developed the first oral therapy for lupus nephritis, a severe kidney disease that can lead to kidney failure, cardiac events, and death.
Explore Aurinia Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.